Sidhu Bharat, Mavilakandy Akash, Hull Katherine L, Koev Ivelin, Vali Zakariyya, Burton James O, Ng G André
Department of Cardiovascular Sciences, University of Leicester, LE1 7RH Leicester, UK.
Department of Cardiology, University Hospitals of Leicester NHS Trust, LE1 5WW Leicester, UK.
Rev Cardiovasc Med. 2024 Apr 9;25(4):143. doi: 10.31083/j.rcm2504143. eCollection 2024 Apr.
Chronic kidney disease (CKD) and atrial fibrillation (AF) are associated with significant cardiovascular morbidity and mortality. Recent studies have highlighted an increased prevalence and incidence of AF in patients with CKD. This article aims to provide a comprehensive review of current management strategies and considerations of treating atrial fibrillation with concomitant CKD. Potential electrophysiological mechanisms between AF and CKD are explored. Current evidence and literature focusing on pharmacological rate and rhythm control along with procedural intervention is reviewed and presented. The management of AF and CKD together is complex, but particularly pertinent when considering the close cyclical relationship in the progression of both diseases.
慢性肾脏病（CKD）和心房颤动（AF）与显著的心血管发病率和死亡率相关。近期研究强调了CKD患者中AF患病率和发病率的增加。本文旨在全面综述当前治疗合并CKD的心房颤动的管理策略及注意事项。探讨了AF与CKD之间潜在的电生理机制。对聚焦于药物心率和节律控制以及手术干预的现有证据和文献进行了综述和阐述。AF和CKD的共同管理很复杂，但在考虑两种疾病进展中的紧密循环关系时尤为相关。
